GT Biopharma GTBP
NASDAQ GTBP
$5.41 -1.90 (-25.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Dividends payables (2025)

Updated

GT Biopharma's Dividends payables was $144,000 in Q3 2025, up 69.4% from the prior quarter.

Analysis

GT Biopharma (GTBP) Dividends payables (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 2.13 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.45 Bn
10 GT Biopharma 6.53 Mn -16.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 144,000.00
Jun 30, 2025 85,000.00
API Access

GT Biopharma Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=GTBP&period=max&api_key=YOUR_API_KEY